Pro Dex Inc (PDEX) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pro dex Inc   (NASDAQ: PDEX)


Pro Dex Inc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pro Dex Inc's ROI in the first quarter of 2026?
Pro dex Inc achieved a return on average invested assets (ROI) of 19.03 % in its first quarter of 2026, this is above PDEX's average return on investment of 13.64%.
Pro Dex Inc invested over the 12 months ending in its first quarter of 2026 $63 million

ROI fell compared to the fourth quarter of 2026, despite the net income growth of 6.69% from the fourth quarter of 2026.

Within the Healthcare sector 40 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 260 to 300.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
I. Quarter		 (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter
Y / Y Investment Change TTM 8.24 % 10.17 % 24.95 % 25.5 % 44.25 %
Y / Y Net Income Change TTM 7.49 % 52.17 % 54.25 % 151.64 % 353.85 %
Investment (TTM) in Millions 64 80 60 50 54
Return On Investment (TTM) 19.03 % 22.44 % 20.41 % 20.17 % 19.17 %
PDEX's Overall Ranking # 300 # 260 # 217 # 248 #
Seq. Investment Change TTM 3.8 % 3.54 % 4.59 % -3.71 % 5.65 %
Seq. Net Income Change TTM -11.95 % 13.83 % 5.85 % 1.31 % 24.66 %
Net Income (TTM) in Millions 12 14 12 11 11

PDEX Company Profile >> Back to PDEX Roi Comparisons >> See Annual PDEX Return On Investment



Return On Investment PDEX's Ranking
Within: No.
Industry # 6
Sector # 41
Overall # 300

Return On Investment Statistics
High Average Low
45.05 %
13.64 %
-18.6 %
(Mar 31 2017)   (Jun 30 2013)







Financial Statements
Pro Dex Inc's I. Quarter Investments $ 64 Millions PDEX's Balance sheet
Pro Dex Inc's I. Quarter Income $ 3 Millions Quarterly PDEX's Income Statement
PDEX's Income by Division See PDEX's Income by Division


PDEX Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 66 47 38 42 34
Y / Y Investment Growth 42.41 % 21.25 % -8.88 % 24.26 % 5.94 %
Net Income in Millions 14 9 2 7 4
Y / Y Net Income Growth 52.17 % 322.1 % -69.93 % 83.5 % -13.37 %
Annual Return On Investment 20.6 % 19.28 % 5.54 % 16.78 % 11.37 %


Annual Roi Comment
In the fiscal year 2026 ROI improved to 20.6 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PDEX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PDEX's Competitors
Subscribers only: Roi for Pro Dex Inc's Suppliers
Subscribers only: Return On Investment for PDEX's Customers

Other Ratios
PDEX's Roa PDEX's Inventory Turnover Ratio PDEX's Growth Rates PDEX's Dividend Statistics
PDEX's Profitability Ratios PDEX's Asset Turnover Ratio PDEX's Dividend Growth
PDEX's Roe PDEX's Valuation Ratios PDEX's Financial Strength Ratios PDEX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Standard Biotools Inc   23.91 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %

Date modified: 2026-10-30T13:19:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.